Patents by Inventor Celia C. LaBranche

Celia C. LaBranche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions comprising modified HIV envelopes
    Patent number: 11814413
    Abstract: The invention is directed to immunogens and methods for inducing immune responses, comprising methods for germline B cell stimulation and maturation by reverse engineering of HIV-1 envelopes.
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: November 14, 2023
    Assignee: DUKE UNIVERSITY
    Inventors: Barton F. Haynes, David Montefiori, Kevin J. Wiehe, Kevin O. Saunders, Celia C. Labranche
  • CD4-independent HIV envelope proteins as vaccines and therapeutics
    Patent number: 7371846
    Abstract: The invention relates to novel CD4-independent HIV Envelope proteins and uses therefor.
    Type: Grant
    Filed: February 1, 2005
    Date of Patent: May 13, 2008
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: James A. Hoxie, Celia C. LaBranche, Robert W. Doms, Trevor L. Hoffman
  • CD4-independent HIV envelope proteins as vaccines and therapeutics
    Patent number: 6849261
    Abstract: The invention relates to novel CD4-independent HIV Envelope proteins and uses therefor.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: February 1, 2005
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: James A. Hoxie, Celia C. LaBranche, Robert W. Doms, Trevor L. Hoffman
  • CD4-independent HIV envelope proteins as vaccines and therapeutics
    Publication number: 20030091594
    Abstract: The invention relates to novel CD4-independent HIV Envelope proteins and uses therefor.
    Type: Application
    Filed: July 16, 2002
    Publication date: May 15, 2003
    Applicant: University of Pennsylvania
    Inventors: James A. Hoxie, Celia C. LaBranche, Robert W. Doms, Trevor L. Hoffman
  • CD4-independent HIV envelope proteins as vaccines and therapeutics
    Patent number: 6420545
    Abstract: The invention relates to novel CD4-independent HIV Envelope proteins and uses therefor.
    Type: Grant
    Filed: June 22, 1999
    Date of Patent: July 16, 2002
    Assignees: The Trustees of the University of Pennsylvania, Duke University
    Inventors: James A. Hoxie, Celia C. LaBranche, Robert W. Doms, Trevor L. Hoffman